title: Orexin A attenuates unconditioned sexual motivation in male rats.
abstract: Orexins are neuropeptides involved in multiple neurophysiological functions such as reward and motivation. However, it is not clear whether orexins are implicated in sexual motivation. This study aims to evaluate the effects of orexin A and the OX(1)R antagonist SB334867 on unconditioned sexual motivation. Forty-five male Wistar rats are divided into four groups. The four groups are respectively administered intracerebroventricularly with saline, orexin A (1, 10 microg), 10% DMSO (cyclodextrin) and SB334867 (5, 15 microg) 10-15 min before sexual motivation tests. The preference for a receptive female to a male in an open arena with two tethered animals is designated as unconditioned sexual motivation. The results show that orexin A reduces the female preference (reducing time in the female zone and/or increasing time in the male zone), the number of visits for the female zone and the total distance traveled in sexually high-motivated males. SB334867 has no effect on the female preference, the number of visits and the distance traveled in either sexually high-motivated or low-motivated males. Our experiments reveal that centrally administered orexin A attenuates sexual motivation in high-motivated males although endogenous orexin A might not play an important role in the expression of unconditioned sexual motivation.
authors.affiliation: Key Laboratory of Mental Heath, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.
authors.forename: Y J
authors.initials: YJ
authors.lastname: Bai
authors.forename: Y H
authors.initials: YH
authors.lastname: Li
authors.forename: X G
authors.initials: XG
authors.lastname: Zheng
authors.forename: J
authors.initials: J
authors.lastname: Han
authors.forename: X Y
authors.initials: XY
authors.lastname: Yang
authors.forename: N
authors.initials: N
authors.lastname: Sui
mesh_terms: D000818:Animals; D001583:Benzoxazoles / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D007276:Injections, Intraventricular; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D009042:Motivation; D009287:Naphthyridines; D009479:Neuropeptides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D064446:Orexin Receptors; D000068797:Orexins; D010052:Ovariectomy; D051381:Rats; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors*; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors*; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D013238:Stereotaxic Techniques; D014508:Urea / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: C420062:1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea; D001583:Benzoxazoles; D047908:Intracellular Signaling Peptides and Proteins; D009287:Naphthyridines; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide; D014508:Urea